The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
as you're aging your testosterone and you let's say as you're aging and if you have metabolic syndrome your testosterone levels will go down your estrogen levels will go up and that can result in prostatic growth but it's typically more adoma growth in the transition zone causing lower urinary tract symptoms so benign growth
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.